Role of inhibin in normal and high-risk pregnancy

Seminars in Reproductive Medicine

Volumn 22, Issue 3, 2004, Pages 227-234

  Muttukrishna, Shanthi ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Inhibin; Miscarriage; Placenta; Preeclampsia; Pregnancy

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; GLYCOPROTEIN; INHIBIN; INHIBIN A; INHIBIN B;

CONTROLLED STUDY; DOWN SYNDROME; FEEDBACK SYSTEM; FETOPLACENTAL UNIT; FETUS GROWTH; FIRST TRIMESTER PREGNANCY; FOLLITROPIN RELEASE; GROWTH RETARDATION; HALF LIFE TIME; HIGH RISK POPULATION; HORMONE DETERMINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS FUNCTION; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; PLACENTA FUNCTION; PREECLAMPSIA; PREGNANCY COMPLICATION; REVIEW; SECOND TRIMESTER PREGNANCY; SPONTANEOUS ABORTION; SYMPTOMATOLOGY;

ABORTION, HABITUAL; DOWN SYNDROME; FEMALE; HUMANS; INHIBINS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY, ECTOPIC; TROPHOBLASTIC NEOPLASMS;

EID: 4344626043     PISSN: 15268004     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-831898     Document Type: Review

References (86)

1. Ying S-Y. Inhibins, activins and follistatins: gonadal proteins modulating the secretion of follicle stimulating hormone. Endocr Rev 1988;9:267-293
2. Mather JP, Moore A, Li RH. Activins, inhibins, and follistatins: further thoughts on a growing family of regulators. Proc Soc Exp Biol Med 1997;215:209-222
3. Groome NP, Illingworth PJ, O'Brien M, et al. Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay. Clin Endocrinol (Oxf) 1994;40:717-723
4. Groome NP, Illingworth PJ, O'Brien M, et al. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 1996;81:1321-1325
5. Muttukrishna S, Child TJ, Groome NP, Ledger WL. Source of circulating levels of inhibin A, pro alpha C-containing inhibins and activin A in early pregnancy. Hum Reprod 1997;12:1089-1093
6. Lockwood GM, Ledger WL, Barlow DH, Groome NP, Muttukrishna S. Measurement of inhibin and activin in early human pregnancy: demonstration of feto-placental origin and role in prediction of early pregnancy outcome. Biol Reprod 1997;57:1490-1494
7. Riley SC, Neville CW, Chard T, Groome NP, Wallace E. Inhibin in extra-embryonic coelomic and amniotic fluids and maternal serum in early pregnancy. Hum Reprod 1996;11:2772-2776
8. Wallace EM, Riley SC, Crossley JA, et al. Dimeric inhibins in amniotic fluid, maternal serum and fetal serum in human pregnancy. J Clin Endocrinol Metab 1997;82:218-222
9. McLachlan RI, Healy DL, Robertson DM, Burger HG, de Kretser DM. Circulating immunoreactive inhibin in the luteal phase and early gestation in women undergoing ovulation induction. Fertil Steril 1987;48:1001-1005
10. Abe Y, Hasegawa Y, Miyamoto K, et al. High concentrations of plasma immunoreactive inhibin during normal pregnancy in women. J Clin Endocrinol Metab 1990;71:133-137
11. Tabie T, Ochiai K, Terashima Y, Takanashi N. Serum levels of inhibin in maternal and umbilical blood during pregnancy. Am J Obstet Gynecol 1991;164:896-900
12. Yohkaichiya T, Polson D, O'Connor A, et al. Concentrations of immunoreactive inhibin in serum during human pregnancy: evidence for an ovarian contribution. Reprod Fertil Dev 1991;3:671-678
13. Baird DT, Smith KB. Inhibin and related peptides in the regulation of reproduction. Oxf Rev Reprod Biol 1993;15:191-232
14. McLachlan RI, Robertson DM, Burger HG, de Kretser DM. The radioimmunoassay of bovine and human follicular fluid and serum inhibin. Mol Cell Endocrinol 1986;46:175-185
15. Muttukrishna S, George L, Fowler PA, Groome NP, Knight PG. Measurement of serum concentrations of inhibin A (α-βA dimer) during human pregnancy. Clin Endocrinol (Oxf) 1995;42:391-397
16. Illingworth PJ, Groome NP, Duncan WC, et al. Measurement of circulating inhibin forms during the establishment of pregnancy. J Clin Endocrinol Metab 1996;81:1471-1475
17. Fowler PA, Evans LW, Groome NP, Templeton A, Knight PG. A longitudinal study of maternal serum inhibin-A, inhibin-B, activin-A, activin-AB, pro-alphaC and follistatin during pregnancy. Hum Reprod 1998;13:3530-3536
18. Petraglia F, Garuti GC, Calza L, et al. Inhibin subunits in human placenta: localization and messenger ribonudeic acid levels during pregnancy. Am J Obstet Gynecol 1991;165:750-758
19. Petraglia F, Gallinelli A, Grande A, et al. Local production and action of follistatin in human placenta. J Clin Endocrinol Metab 1994;78:205-210
20. Petraglia F, Calza L, Garuti GC, et al. Presence and synthesis of inhibin subunits in human decidua. J Clin Endocrinol Metab 1990;71:487-492
21. Petraglia F, Lim ATW, Rivier J, Vale W. Localisation, secretion and action of inhibin in human placenta. Science 1987;237:187-189
22. Minami S, Yamoto M, Nakano R. Immunohistochemical localization of inhibin/activin subunits in human placenta. Obstet Gynecol 1992;80:410-414
23. McCluggage WG, Ashe P, McBride H, Maxwell P, Sloan JM. Localization of the cellular expression of inhibin in trophoblastic tissue. Histopathology 1998;32:252-256
24. Yamoto M, Minami S, Nakano R. Immunohistochemical localization of inhibin subunits in human corpora lutea during menstrual cycle and pregnancy. J Clin Endocrinol Metab 1991;73:470-477
25. Birdsall M, Ledger WL, Groome NP, Abdalla H, Muttukrishna S. Inhibin A and activin A in the first trimester of human pregnancy. J Clin Endocrinol Metab 1997;82:1557-1560
26. Riley SC, Leask R, Balfour C, Brennand JE, Groome N. Production of inhibin forms by the fetal membranes, decidua, placenta and fetus at parturition. Hum Reprod 2000;15:578-583
27. Riley SC, Balfour C, Wathen NC, et al. Follistatin and activin A in extra embryonic coelomic and amniotic fluids and maternal serum in early pregnancy. Hum Reprod 1998;13:2624-2628
28. Luisi S, Battaglia C, Florio P, et al. Activin A and inhibin B in extra -embryonic coelomic and amniotic fluids and maternal serum in early pregnancy. Placenta 1998;19:435-438
29. Muttukrishna S, Chamberlain P, Evans LW, Asselin J, Groome NP, Ledger WL. Amniotic fluid concentrations of dimeric inhibins, activin A and follistatin in pregnancy. Eur J Endocrinol 1999;140:420-424
30. Muttukrishna S, Jauniaux E, Pahal G, Groome NP, Rodeck CH. In vivo distribution of inhibin A, activin A and follistatin in early pregnancy. Presented at the European Congress in Obstetrics and Gynaecology Ceska Gynekol 2002;2(suppl): 76
31. Debieve F, Beerlandt S, Hubinont C, Thomas K. Gonadotropins, prolactin, inhibin A, inhibin B and activin A in human fetal serum from midpregnancy and term pregnancy. J Clin Endocrinol Metab 2000;85:270-274
32. Florio P, Severi FM, Luisi S, et al. Abnormal umbilical artery Doppler waveforms and cord blood inhibin A and inhibin B levels. Biol Neonate 2003;84:281-286
33. Jenkin G, McFarlane JR, de Kretser DM. Implication of inhibin and related proteins in fetal development. Reprod Fertil Dev 1995;7:323-331
34. Qu J, Thomas K. Regulation of inhibin secretion in human placental cell culture by epidermal growth factor, transforming growth factors and activin. J Clin Endocrinol Metab 1993;77:925-931
35. Qu J, Thomas K. Prostaglandins stimulate the secretion of inhibin from human placental cells. J Clin Endocrinol Metab 1993;77:556-564
36. Keelan J, Song Y, France JT. Comparative regulation of inhibin, activin and human chorionic gonadotrophin production by placental trophoblast cells in culture. Placenta 1994;15:803-818
37. Bandivdekar AH, Varadkar AM, Sheth AR. Endocrine control of inhibin biosynthesis by human placenta. Biol Res Pregnancy Perinatol 1985;6:128-132
38. Mohan A, Asselin J, Sargent IL, Groome NP, Muttukrishna S. Effect of cytokines and growth factors on the secretion of inhibin A, activin A and follistatin by term placental villous trophoblasts in culture. Eur J Endocrinol 2001;145:505-511
39. Manuelpillai U, Schneider-Kolsky M, Thirunavukarasu P, Dole A, Waldron K, Wallace EM. Effect of hypoxia on placental activin A, inhibin A and follistatin synthesis. Placenta 2003;24:77-83
40. Blumenstein M, Mitchell MD, Groome NP, Keelan JA. Hypoxia inhibits activin A production by term villous trophoblast in vitro. Placenta 2002;23:735-741
41. Petraglia F, Vaughan J, Vale W. Inhibin and activin modulate the release of gonadotropin-releasing hormone, human chorionic gonadotropin, and progesterone from cultured human placental cells. Proc Natl Acad Sci USA 1989;86:5114-5117
42. Mersol-Barg MS, Miller KF, Choi CM, Lee AC, Kim MI. Inhibin suppresses chorionic gonadotrophin secretion in term but not first trimester placenta. J Clin Endocrinol Metab 1990;71:1294-1298
43. Steele GL, Currie WD, Yuen BH, Jia XC, Perlas E, Leung PCK. Acute stimulation of chorionic gonadotrophin secretion by recombinant human activin A in first trimester human trophoblast. Endocrinology 1993;133:297-303
44. Leung PH, Salamonsen L-A, Findlay JK. Immunolocalization of inhibin and activin subunits in human endometrium across the menstrual cycle. Hum Reprod 1998;13:3469-3477
45. Ethier JF, Findlay JK. Roles of activin and its signal transduction mechanisms in reproductive tissue. Reproduction 2001;121:667-675
46. Otani T, Minami S, Yamoto M, Umesaki N. Production of activin A in hyperplasia and adenocarcinoma of the human endometrium. Gynecol Oncol 2001;83:31-38
47. Jones RL, Salamonsen LA, Critchley HO, Rogers PA, Affandi B, Findlay JK. Inhibin and activin subunits are differentially expressed in endometrial cells and leukocytes during the menstrual cycle, in early pregnancy and in women using progestin-only contraception. Mol Hum Reprod 2000;6:1107-1117
48. Healy DL, Mamers P, Bangah M, Burger HG. Clinical and pathophysiological aspects of inhibin. Hum Reprod 1993;8:138-140
49. Yohkaichiya T, Fudaya T, Hoshiai H, Yajima A, de Kretser DM. Inhibin, a new circulating marker in hydatidiform mole. BMJ 1989;298:1684-1686
50. Minami S, Yamoto M, Nakano R. Immunohistochemical localisation of inhibin-activin subunits in hydatidiform mole and invasive mole. Obstet Gynecol 1993;82:414-418
51. Kato T, Seki K, Matsui H, Sekiya S. Circulating inhibin forms in patients with hydatidiform mole. Gynecol Obstet Invest 2002;54:114-117
52. Florio P, Severi FM, Cobellis L, et al. Serum activin A and inhibin A: new clinical markers for hydatidiform mole. Cancer 2002;94:2618-2622
53. Yohkaichiya T, Polson DW, Hughes EG, et al. Serum immunoreactive inhibin levels in early pregnancy after in vitro fertilisation and embryo transfer. Fertil Steril 1993;59:1081-1089
54. Seifer DB, Labertmesserlian GM, Canick JA, Frishman GN, Schneyer AL. Serum inhibin levels are lower in ectopic than intrauterine spontaneously conceived pregnancies. Fertil Steril 1996;65:667-669
55. Lockwood GM, Ledger WL, Barlow DH, Groome NP, Muttukrishna S. Identification of the source of inhibins at the time of conception provides a diagnostic role for them in very early pregnancy. Am J Reprod Immunol 1998;40:303-308
56. Muttukrishna S, Jauniaux E, Greenwold N, et al. Levels of inhibin A, activin A and follistatin in missed and recurrent miscarriages. Hum Reprod 2002;17:3072-3078
57. Luisi S, Florio P, D'Antona D, et al. Maternal serum inhibin A levels are a marker of a viable trophoblast in incomplete and complete miscarriage. Eur J Endocrinol 2003;148:233-236
58. Van Lith JM, Pratt JJ, Beekhuis JR, Mantingh A. Second trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome. Prenat Diagn 1992;12:801-806
59. Spencer K, Wood PJ, Antony FW. Elevated levels of maternal serum inhibin immunoreactivity in second trimester pregnancies affected by Down's syndrome. Ann Clin Biochem 1993;30:219-220
60. Cuckle HS, Holding S, Jones R. Maternal serum inhibin levels in second trimester Down's syndrome pregnancies. Prenat Diagn 1994;14:387-390
61. Cuckle HS, Holding S, Jones R, Wallace EM, Groome NP. Maternal serum dimeric inhibin A in second trimester Down's syndrome pregnancies. Prenat Diagn 1995;15:385-392
62. Canick JA, Lambert-Messerlian GM, Palomaki GE, et al. Maternal serum dimeric inhibin is elevated in Down's syndrome pregnancy. Am J Hum Genet 1994;55:A37
63. Aitken DA, Wallace EM, Crossley JA, et al. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy. N Engl J Med 1996;334:1231-1236
64. Wallace EM, Healy DL. Inhibins and activins: roles in clinical practice. Br J Obstet Gynaecol 1996;103:945-956
65. Tul N, Pusenjak S, Osredkar J, Spencer K, Novak-Antolic Z. Predicting complications of pregnancy with first trimester maternal serum free-beta hCG, PAPP A and inhibin A. Prenat Diagn 2003;23:990-996
66. Benn PA, Fang M, Egan JF, Horne D, Collins R. Incorporation of inhibin A in second trimester screening for Down syndrome. Obstet Gynecol 2003;101:451-454
67. Dalgliesh GL, Aitken DA, Lyall F, Howatson AG, Connor JM. Placental and maternal serum inhibin-A and activin-A levels in Down's syndrome pregnancies. Placenta 2001;22:227-234
68. Wallace EM, Crossley JA, Groome NP, Aitken DA. Amniotic fluid inhibin-A in chromosomally normal and Down's syndrome pregnancies. J Endocrinol 1997;152:109-112
69. Muttukrishna S, Knght G, Groome NP, Redman CWG, Ledger WL. Inhibin A and activin A: new endocrine markers for pre-eclampsia? Lancet 1997;349:1285-1288
70. Cuckle H, Sehmi I, Jones R. Maternal serum inhibin A can predict pre-eclampsia. Br J Obstet Gynaecol 1998;105:1101-1103
71. Lambert-Messerlian GM, Silver HM, Petraglia F, et al. Second-trimester levels of maternal serum human chorionic gonadotropin and inhibin A as predictors of preeclampsia in the third trimester of pregnancy. J Soc Gynecol Investig 2000;7:170-174
72. Muttukrishna S, North RA, Morris J, et al. Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia. Hum Reprod 2000;15:1640-1645
73. Grobman WA, Wang EY. Serum levels of activin A and inhibin A and the subsequent development of preeclampsia. Obstet Gynecol 2000;96:390-394
74. Davidson EJ, Riley SC, Roberts SA, Shearing CH, Groome NP, Martin CW. Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia. BJOG 2003;110:46-52
75. Keelan JA, Taylor R, Schellenberg J-C, Groome NP, Mitchell MD, North RA. Serum activin A, inhibin A and follistatin concentrations in pre-eclampsia or small for gestational age pregnancies. Obstet Gynecol 2002;99:267-274
76. Florio P, Cobellis L, Luisi S, et al. Changes in inhibins and activin secretion in healthy and pathological pregnancies. Mol Cell Endocrinol 2001;180:123-130
77. Florio P, Ciarmela P, Luisi S, et al. Pre-eclampsia with fetal growth restriction: placental and serum activin A and inhibin A levels. Gynecol Endocrinol 2002;16:365-372
78. Silver HM, Lambert-Messerlian GM, Reis FM, Diblasio AM, Petraglia F, Canick JA. Mechanism of increased maternal serum total activin A and inhibin A in pre eclampsia. J Soc Gynecol Investig 2002;9:308-312
79. Bersinger NA, Groome NP, Muttukrishna S. Pregnancy-associated and placental proteins in the placental tissue of normal and pre-eclamptic women at delivery. Eur J Endocrinol 2002;147:785-793
80. Casagrandi D, Bearfield C, Geary J, Redman CW, Muttukrishna S. Inhibin, activin, follistatin, activin receptors and betaglycan gene expression in the placental tissue of pre eclampsia patients. Mol Hum Reprod 2003;9:199-203
81. Bobrow CS, Holmes RP, Muttukrishna S, et al. Maternal serum activin A, inhibin A and follistatin in pregnancies with appropriately grown and small for gestational age fetuses classified by umbilical artery Doppler. Am J Obstet Gynecol 2002;186:283-287
82. D'Antona D, Reis FM, Benedetto C, et al. Increased maternal serum activin A but not follistatin levels in pregnant women with hypertensive disorders. J Endocrinol 2000;165:157-162
83. Jauniaux E, Watson AL, Hempstock J, Bao YP, Skepper JN, Burton GJ. Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. Am J Pathol 2000;157:2111-2122
84. Hustin J, Jauniaux E, Schaaps JP. Histological study of the materno-embryonic interface in spontaneous abortion. Placenta 1990;11:477-486
85. Jauniaux E, Hempstock J, Greenwold N, Burton GJ. Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. Am J Pathol 2003;162:115-125
86. Hung TH, Skepper JN, Burton GJ. In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies. Am J Pathol 2001;159:1031-1043